MPD: Phenotype measures mapped to VT:0010531, operant conditioning behavior trait

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
CSNA03:449	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), founders [n] acquisition_in 110188	inbred w/CC8	7	both	4-25wks	N=10	2018

CSNA03:450	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC [n] acquisition_cc 110390	CC w/par	53	both	4-25wks	N=4	2018

CSNA03:452	CSNA03	operant conditioning chamber	cocaine	dose response, number of infusions (intravenous self administration), founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	inbred w/CC8	8	both	4-25wks	N=14	2018

CSNA03:461	CSNA03	operant conditioning chamber	cocaine	dose response, number of infusions (intravenous self administration), CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	CC w/par	57	both	4-25wks	N=6	2018

CSNA03:479	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:488	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:506	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:515	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:533	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:535	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:540	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:542	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:547	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:549	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:554	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:556	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:558	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:560	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:562	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:564	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:566	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_JAX 113850	inbred w/CC8	8	both		N=7	2021

CSNA03:567	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_JAX 113851	CC w/par	52	both		N=3	2021

CSNA03:568	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853	DO population w/par	9	both		N=28	2021

CSNA03:569	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:571	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:573	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:575	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:577	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:579	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:581	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:583	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:585	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:587	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:589	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:591	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:593	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:595	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:597	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:605	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:607	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:609	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:617	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:619	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:621	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:623	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:625	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:627	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:629	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:631	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:633	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:635	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:637	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:639	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:641	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:643	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:645	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:647	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:649	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:651	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_Binghamton 113852	inbred w/CC8	8	both		N=5	2021

CSNA03:652	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_Binghamton 113854	CC w/par	18	both		N=4	2021

CSNA03:653	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:655	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:657	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:659	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:661	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:663	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:665	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:667	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:669	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:671	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:673	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:675	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:677	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:679	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:681	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:683	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal	CC w/par	18	both		N=4	2021

Dickson1:1	Dickson1	operant conditioning chamber	(none)	goal-tracking [s] GTdur_all 54601 unpaired paired	inbred	5	both	12-20wks	N=5	2015

Dickson1:11	Dickson1	operant conditioning chamber	(none)	sign-tracking [s] STdur_all 54611 unpaired paired	inbred	5	both	12-20wks	N=5	2015

Dickson2:31	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of infusions (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_infusions_mean 54831	DO population		both	12-16wks	N=35	2015

Dickson2:32	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of responses on the active lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_active_mean 54832	DO population		both	12-16wks	N=35	2015

Dickson2:33	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of responses on the inactive lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_inactive_mean 54833	DO population		both	12-16wks	N=35	2015

Dickson2:41	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, breakpoint for infusions (progressive ratio (PR) schedule), one 6h test [n] PR_infusions_breakpoint 54841	DO population		both	12-16wks	N=31	2015

Dickson2:42	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, number of presses on the active lever (progressive ratio (PR) schedule), one 6h test [n] PR_active 54842	DO population		both	12-16wks	N=31	2015

Dickson2:43	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, number of presses on the inactive lever (progressive ratio (PR) schedule), one 6h test [n] PR_inactive 54843	DO population		both	12-16wks	N=31	2015

Jentsch1:1	Jentsch1	operant conditioning chamber	(none)	number of initiated trials per daily session, acquisition phase [n] acq_initiated_trials 40301	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:2	Jentsch1	operant conditioning chamber	(none)	number of trials with no choice made in first 30 s, acquisition phase [n] acq_no_choice 40302	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:3	Jentsch1	operant conditioning chamber	(none)	average number of anticipatory responses per trial, acquisition phase [n] acq_anticipatory 40303	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:4	Jentsch1	operant conditioning chamber	(none)	average latency to initiate trial, acquisition phase [s] acq_latency_trial 40304	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:5	Jentsch1	operant conditioning chamber	(none)	average latency to make correct choice, acquisition phase [s] acq_latency_correct 40305	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:6	Jentsch1	operant conditioning chamber	(none)	average latency to retrieve food reward, acquisition phase [s] acq_latency_reward 40306	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:7	Jentsch1	operant conditioning chamber	(none)	number of initiated trials per daily session, reversal phase [n] revers_init_trials 40307	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:8	Jentsch1	operant conditioning chamber	(none)	number of trials with no choice made in first 30 s, reversal phase [n] revers_no_choice 40308	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:9	Jentsch1	operant conditioning chamber	(none)	average number of anticipatory responses per trial, reversal phase [n] revers_anticipatory 40309	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:10	Jentsch1	operant conditioning chamber	(none)	average latency to initiate trial, reversal phase [s] revers_latency_trial 40310	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:11	Jentsch1	operant conditioning chamber	(none)	average latency to make correct choice, reversal phase [s] revers_latency_correct 40311	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:12	Jentsch1	operant conditioning chamber	(none)	average latency to retrieve food reward, reversal phase [s] revers_latency_reward 40312	BXD w/par	53	m	17wks	N=3	2011

Jentsch2:1	Jentsch2	operant conditioning chamber	cocaine	number of sessions (days) required to reach criteria for self-administration (FR1 reinforcement schedule) [d] acquisition_FR1 49701	BXD	4	both	8-17wks	N=8	2013

Jentsch2:2	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 1 - self administration: number of infusions earned [n] infusions_FR1 49702 day 1 day 3 day 5 last day	BXD	4	both	8-17wks	N=8	2013

Jentsch2:6	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 1 - discrimination index between active and inactive levers [%] discrimination_FR1 49706 day 1 day 3 day 5 last day	BXD	4	both	8-17wks	N=7	2013

Jentsch2:10	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 1 - time-out: number of responses [n] timeout_FR1 49710 day 1 day 3 day 5 last day	BXD	4	both	8-17wks	N=7	2013

Jentsch2:14	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 2 - self administration: number of infusions earned [n] infusions_FR2 49714 day 1 day 2 day 4	BXD	4	both	8-17wks	N=6	2013

Jentsch2:17	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 2 - discrimination index between active and inactive levers [%] discrimination_FR2 49717 day 1 day 2 day 4	BXD	4	both	8-17wks	N=6	2013

Jentsch2:20	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 2 - time-out: number of responses [n] timeout_FR2 49720 day 1 day 2 day 4	BXD	4	both	8-17wks	N=6	2013

Jentsch2:23	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 5 - self administration: number of infusions earned [n] infusions_FR5 49723 day 1 day 3 day 5	BXD	4	both	8-17wks	N=6	2013

Jentsch2:26	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 5 - discrimination index between active and inactive levers [%] discrimination_FR5 49726 day 1 day 3 day 5	BXD	4	both	8-17wks	N=6	2013

Jentsch2:29	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 5 - time-out: number of responses [n] timeout_FR5 49729 day 1 day 3 day 5	BXD	4	both	8-17wks	N=6	2013

Schalkwyk1:18	Schalkwyk1	puzzle box	(none)	latency to reach goal during training, 3 min test [s] laten_goal_PBtrain 34518	inbred	8	m	9-11wks	N=11	2010

Schalkwyk1:19	Schalkwyk1	puzzle box	(none)	latency to reach goal during burrowing task, 3 min test [s] laten_goal_PBbur 34519	inbred	8	m	9-11wks	N=11	2010

Schalkwyk1:20	Schalkwyk1	puzzle box	(none)	latency to reach goal during plug task, 3 min test [s] laten_goal_PBplug 34520	inbred	8	m	9-11wks	N=11	2010

Spijker1:19	Spijker1	choice serial reaction time task	(none)	percentage of total Reponses that are correct, stimulus duration fixed, 1s [%] accuracy_SD1 40619	BXD w/par	43	m	8wks	N=13	2011

Spijker1:20	Spijker1	choice serial reaction time task	(none)	percentage of events that are omission errors, stimulus duration fixed, 1s [%] omission_SD1 40620	BXD w/par	43	m	8wks	N=13	2011

Spijker1:21	Spijker1	choice serial reaction time task	(none)	correct response latency, stimulus duration fixed, 1s [s] latency_correct 40621	BXD w/par	43	m	8wks	N=13	2011

Spijker1:22	Spijker1	choice serial reaction time task	(none)	mode of correct response latencies, stimulus duration fixed, 1s [s] latency_mode 40622	BXD w/par	43	m	8wks	N=13	2011

Spijker1:23	Spijker1	choice serial reaction time task	(none)	individual variability of correct response latency [s] variability_SD1 40623	BXD w/par	43	m	8wks	N=13	2011

Spijker1:24	Spijker1	choice serial reaction time task	(none)	latency between correct response and head entry detected in food magazine, stimulus duration fixed, 1s [s] latency_reward 40624	BXD w/par	43	m	8wks	N=13	2011

Spijker1:25	Spijker1	choice serial reaction time task	(none)	number of initiated trials, stimulus duration 1s [n] trials_initiated 40625	BXD w/par	43	m	8wks	N=13	2011

Spijker1:26	Spijker1	choice serial reaction time task	(none)	percentage of total responses that are correct, stimulus duration variable [%] accuracy_SDvar 40626	BXD w/par	43	m	8wks	N=13	2011

Spijker1:27	Spijker1	choice serial reaction time task	(none)	percentage of events that are omission errors, stimulus duration variable [%] omission_SDvar 40627	BXD w/par	43	m	8wks	N=13	2011

Spijker2:27	Spijker2	choice serial reaction time task	(none)	anticipatory magazine response, 25 min test [n] magazine_resp 44027	inbred	12	m	6wks	N=12	2009

Spijker2:28	Spijker2	choice serial reaction time task	(none)	latency to collect food from magazine, 25 min test [s] lat_food 44028	inbred	12	m	6wks	N=12	2009

Spijker2:29	Spijker2	choice serial reaction time task	(none)	impulsivity, 25 min test [%] impulsivity 44029	inbred	12	m	6wks	N=12	2009

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), founders [n] acquisition_in 110188

inbred w/CC8

7

both

4-25wks

N=10

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC [n] acquisition_cc 110390

CC w/par

53

both

4-25wks

N=4

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

inbred w/CC8

8

both

4-25wks

N=14

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

CC w/par

57

both

4-25wks

N=6

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_JAX 113850

inbred w/CC8

8

both

N=7

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_JAX 113851

CC w/par

52

both

N=3

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853

DO population w/par

9

both

N=28

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_Binghamton 113852

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_Binghamton 113854

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal

CC w/par

18

both

N=4

2021

Dickson1

operant conditioning chamber

(none)

goal-tracking [s] GTdur_all 54601 unpaired paired

inbred

5

both

12-20wks

N=5

2015

Dickson1

operant conditioning chamber

(none)

sign-tracking [s] STdur_all 54611 unpaired paired

inbred

5

both

12-20wks

N=5

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, mean number of infusions (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_infusions_mean 54831

DO population

both

12-16wks

N=35

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, mean number of responses on the active lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_active_mean 54832

DO population

both

12-16wks

N=35

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, mean number of responses on the inactive lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_inactive_mean 54833

DO population

both

12-16wks

N=35

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, breakpoint for infusions (progressive ratio (PR) schedule), one 6h test [n] PR_infusions_breakpoint 54841

DO population

both

12-16wks

N=31

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, number of presses on the active lever (progressive ratio (PR) schedule), one 6h test [n] PR_active 54842

DO population

both

12-16wks

N=31

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, number of presses on the inactive lever (progressive ratio (PR) schedule), one 6h test [n] PR_inactive 54843

DO population

both

12-16wks

N=31

2015

Jentsch1

operant conditioning chamber

(none)

number of initiated trials per daily session, acquisition phase [n] acq_initiated_trials 40301

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

number of trials with no choice made in first 30 s, acquisition phase [n] acq_no_choice 40302

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average number of anticipatory responses per trial, acquisition phase [n] acq_anticipatory 40303

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to initiate trial, acquisition phase [s] acq_latency_trial 40304

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to make correct choice, acquisition phase [s] acq_latency_correct 40305

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to retrieve food reward, acquisition phase [s] acq_latency_reward 40306

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

number of initiated trials per daily session, reversal phase [n] revers_init_trials 40307

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

number of trials with no choice made in first 30 s, reversal phase [n] revers_no_choice 40308

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average number of anticipatory responses per trial, reversal phase [n] revers_anticipatory 40309

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to initiate trial, reversal phase [s] revers_latency_trial 40310

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to make correct choice, reversal phase [s] revers_latency_correct 40311

BXD w/par

53

m

17wks

N=3

2011

Jentsch1

operant conditioning chamber

(none)

average latency to retrieve food reward, reversal phase [s] revers_latency_reward 40312

BXD w/par

53

m

17wks

N=3

2011

Jentsch2

operant conditioning chamber

cocaine

number of sessions (days) required to reach criteria for self-administration (FR1 reinforcement schedule) [d] acquisition_FR1 49701

BXD

4

both

8-17wks

N=8

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 1 - self administration: number of infusions earned [n] infusions_FR1 49702 day 1 day 3 day 5 last day

BXD

4

both

8-17wks

N=8

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 1 - discrimination index between active and inactive levers [%] discrimination_FR1 49706 day 1 day 3 day 5 last day

BXD

4

both

8-17wks

N=7

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 1 - time-out: number of responses [n] timeout_FR1 49710 day 1 day 3 day 5 last day

BXD

4

both

8-17wks

N=7

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 2 - self administration: number of infusions earned [n] infusions_FR2 49714 day 1 day 2 day 4

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 2 - discrimination index between active and inactive levers [%] discrimination_FR2 49717 day 1 day 2 day 4

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 2 - time-out: number of responses [n] timeout_FR2 49720 day 1 day 2 day 4

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 5 - self administration: number of infusions earned [n] infusions_FR5 49723 day 1 day 3 day 5

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 5 - discrimination index between active and inactive levers [%] discrimination_FR5 49726 day 1 day 3 day 5

BXD

4

both

8-17wks

N=6

2013

Jentsch2

operant conditioning chamber

cocaine

Fixed ratio 5 - time-out: number of responses [n] timeout_FR5 49729 day 1 day 3 day 5

BXD

4

both

8-17wks

N=6

2013

Schalkwyk1

puzzle box

(none)

latency to reach goal during training, 3 min test [s] laten_goal_PBtrain 34518

inbred

8

m

9-11wks

N=11

2010

Schalkwyk1

puzzle box

(none)

latency to reach goal during burrowing task, 3 min test [s] laten_goal_PBbur 34519

inbred

8

m

9-11wks

N=11

2010

Schalkwyk1

puzzle box

(none)

latency to reach goal during plug task, 3 min test [s] laten_goal_PBplug 34520

inbred

8

m

9-11wks

N=11

2010

Spijker1

choice serial reaction time task

(none)

percentage of total Reponses that are correct, stimulus duration fixed, 1s [%] accuracy_SD1 40619

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

percentage of events that are omission errors, stimulus duration fixed, 1s [%] omission_SD1 40620

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

correct response latency, stimulus duration fixed, 1s [s] latency_correct 40621

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

mode of correct response latencies, stimulus duration fixed, 1s [s] latency_mode 40622

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

individual variability of correct response latency [s] variability_SD1 40623

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

latency between correct response and head entry detected in food magazine, stimulus duration fixed, 1s [s] latency_reward 40624

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

number of initiated trials, stimulus duration 1s [n] trials_initiated 40625

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

percentage of total responses that are correct, stimulus duration variable [%] accuracy_SDvar 40626

BXD w/par

43

m

8wks

N=13

2011

Spijker1

choice serial reaction time task

(none)

percentage of events that are omission errors, stimulus duration variable [%] omission_SDvar 40627

BXD w/par

43

m

8wks

N=13

2011

Spijker2

choice serial reaction time task

(none)

anticipatory magazine response, 25 min test [n] magazine_resp 44027

inbred

12

m

6wks

N=12

2009

Spijker2

choice serial reaction time task

(none)

latency to collect food from magazine, 25 min test [s] lat_food 44028

inbred

12

m

6wks

N=12

2009

Spijker2

choice serial reaction time task

(none)

impulsivity, 25 min test [%] impulsivity 44029

inbred

12

m

6wks

N=12

2009

Filter Table Results